Amy Wakeham | Vice President of Investor Relations and Corporate Communications |
Mick Farrell | Chief Executive Officer |
Brett Sandercock | Chief Financial Officer |
Dave Pendarvis | Chief Administrative Officer, Global General Counsel |
Jim Hollingshead | President, Sleep and Respiratory Care Business |
Rob Douglas | President and Chief Operating Officer |
Chris Cooper | Goldman Sachs |
Sean Laaman | Morgan Stanley |
Gretel Janu | Crédit Suisse |
Margaret Kaczor | William Blair |
David Low | J.P. Morgan |
Lyanne Harrison | Bank of America |
Matthew Mishan | KeyBanc |
Saul Hadassin | UBS |
Suraj Kalia | Oppenheimer |
David Bailey | Macquarie |
Andrew Goodsall | MST Marquee |
Anthony Petrone | Jefferies |
Welcome to the Q1 Fiscal Year 2021 ResMed Earnings Conference Call. My name is Cheryl, and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.